MIS plans to produce radiopharmaceuticals in U.K.
Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a
Molecular Imaging Services has signed an agreement to establish a commercial radiopharmaceutical production unit at Keele University Science Park in Staffordshire, U.K. The unit will produce PET radiopharmaceuticals. MIS was established in 2002 as a joint venture between Phoenix-based Alliance Medical and Dublin-based M2i. Its primary goal is to establish a number of such production units to support the expanded use of PET in the U.K.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.








